After an inspection of its Tokyo facility in November, the US Food and Drug Administration issued a pointed warning letter to Olympus Medical Systems concerning various single-use endoscopes and related accessories that the company manufacturers there.
The FDA’s letter, issued to Olympus on 17 March, accuses Olympus of producing “adulterated” devices, which means the company did...